Crinetics Showcases the Next Generation of Endocrinology Innovation at ENDO 2025
“ENDO 2025 will be an incredibly meaningful moment for Crinetics and our mission to be the premier endocrine-focused global pharmaceutical company.”
– Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics
2025 Presentations
PALSONIFY™ (paltusotine) Presentations:
Atumelnant Presentations:
Early Pipeline Presentations:
Science & Innovation Theaters
Optimizing Long-Term Control in Acromegaly: Key to Improved Patient Outcomes
Presenters: Shlomo Melmed, MB ChB; Christian J. Strasburger, MD
Date/Time: July 14, 9:30 AM-10:30 AM
Navigating the Complexities & Challenges of Acromegaly Management
Presenters: Lisa B. Nachtigall, MD; Laurence Katznelson, MD; Stephen Betz, Ph.D.
Date/Time: July 14, 12:30 PM -1:30 PM
Attending ENDO 2025?
Stop by booth 509 to meet our team in person

Exploring new frontiers with our science to expand patient reach
Our in-house R&D team of proven drug hunters develops transformative novel molecules with a focus on the endocrine system and G-protein coupled receptors. Our pipeline is purposefully created to deliver innovative therapies.
Live from ENDO 2025
ENDO 2024: Tiffany Quock
Crinetics Pharmaceuticals May 23, 2025 2:33 pm
ENDO 2024: Stephanie Kallay
Crinetics Pharmaceuticals May 23, 2025 2:31 pm
ENDO 2024: Garnet Howells
Crinetics Pharmaceuticals May 23, 2025 2:29 pm
ENDO 2024: Michael Keeley
Crinetics Pharmaceuticals May 23, 2025 2:27 pm
ENDO 2024: Lise Kjems
Crinetics Pharmaceuticals May 23, 2025 2:25 pm
ENDO 2024: Stephen Betz
Crinetics Pharmaceuticals May 23, 2025 2:24 pm
ENDO 2024: Dana Pizzuti
Crinetics Pharmaceuticals May 23, 2025 2:19 pm
Private video
Crinetics Pharmaceuticals May 23, 2025 2:14 pm
Connect With Us
For Healthcare Professionals only: Use the form below to submit a general Medical Inquiry.